Influence of mirtazapine on the sexual behavior of male rats
- First Online:
- 95 Downloads
Impairment of sexual activity is one of the most frequent side effects of antidepressant drugs. The increase in the synaptic concentrations of serotonin seems to be mainly responsible. Mirtazapine is a novel antidepressant that increases the synaptic concentrations of both noradrenaline and serotonin; moreover, it is an antagonist at 5-HT2C receptors, whose activation is considered to be responsible for some typical effects of serotonin on the ejaculation process (retardation of ejaculation, anorgasmia).
To study the influence of mirtazapine on copulatory performance and sexual motivation in male rats, in comparison—or in combination—with fluoxetine.
Copulatory performance was studied either in sexually experienced or in sexually naive rats; sexual motivation was studied in sexually experienced rats. Mirtazapine (1, 5 or 10 mg/kg), fluoxetine (10 mg/kg), and the combination of mirtazapine + fluoxetine (10+10 mg/kg) were subcutaneously (s.c.) administered either acutely or daily for 13 days.
After acute administration, mirtazapine decreased mount latency (ML) and intromission latency (IL), and increased mount frequency (MF) and ejaculation latency (EL). Fluoxetine had no significant effect on any of the sexual behavior parameters. After a 13-day treatment, mirtazapine increased ML, IL and MF; fluoxetine increased ML, IL and the intercopulatory interval (ICI); the addition of mirtazapine to fluoxetine produced a reduction of ICI and an increase of MF. Moreover, mirtazapine significantly improved the performance of rats in the sexual motivation test.
The present results show that, on the whole, the acute administration of mirtazapine improves several parameters of the copulatory performance of male rats and strongly stimulates sexual motivation, while the repeated administration produces minor, conflicting effects. This effect of mirtazapine on male rat sexual behavior is to be ascribed to the antagonism at brain α2 adrenergic auto- and hetero-receptors, with consequent increased release of noradrenaline and serotonin, and antagonism at 5-HT2C receptors, which are involved in the negative influence of serotonin on male sexual behavior.
KeywordsMirtazapine Fluoxetine Antidepressants Sexual behavior Male rat
- American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders, 4th edn. rev. American Psychiatric Press, WashingtonGoogle Scholar
- Baldwin DS (1995) Psychotropic drugs and sexual dysfunction. Int Rev Psychiatry 7:261–273Google Scholar
- Balon R, Yeragani VK, Pohl R, Ramesh C (1993) Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 54:209–212Google Scholar
- Beach FA (1956) Characteristics of masculine “sex drive”. In: Jones MR (ed) Nebraska symposium on motivation. University of Nebraska Press, Lincoln, pp 1–31Google Scholar
- Clark JT, Kalra PS, Kalra SP (1987) Effects of a selective alpha-1 adrenoceptor agonist, methoxamine, on sexual behavior and penile reflexes. Physiol Behav 40:747–753Google Scholar
- Crenshaw TL, Goldberg JP (1996) Sexual pharmacology: drugs that affect sexual function. WW Norton, New YorkGoogle Scholar
- Gitlin MJ (1995) Effects of depression and antidepressants on sexual functioning. Bull Manninger Clin 59:232–248Google Scholar
- Herman J, Brotman A, Pollack M, Falk W, Biederman J, Rosenbaum J (1990) Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 51:25–27Google Scholar
- Hirschfeld RM (1999) Care of the sexually active depressed patient. J Clin Psychiatry 60:32–35Google Scholar
- Jacobsen FM (1992) Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 53:119–122Google Scholar
- Lane R, Baldwin D, Preskorn S (1995) The SSRIs: advantages, disadvantages and differences. J Psychopharmacol 9:163–178Google Scholar
- Mendels J, Camera A, Sikes C (1995) Sertraline treatment for premature ejaculation. J Clin Psycopharmacol 15:341–346Google Scholar
- Patterson W (1993) Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 54:71Google Scholar
- Zohar J, Kaplan Z, Benjamin J (1994) Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. J Clin Psychiatry 55:86–88Google Scholar